AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 294: R1205-R1212, 2008. First published February 27, 2008; doi:10.1152/ajpregu.00909.2007
0363-6119/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/R1205    most recent
00909.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Thrush, A. B.
Right arrow Articles by Dyck, D. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thrush, A. B.
Right arrow Articles by Dyck, D. J.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans

A. Brianne Thrush,1 George J. Heigenhauser,2 Kerry L. Mullen,1 David C. Wright,3 and David J. Dyck1

1Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario; 2Department of Medicine, McMaster University, Hamilton, Ontario; and 3Alberta Institute of Human Nutrition, University of Alberta, Edmonton, Alberta, Canada

Submitted 20 December 2007 ; accepted in final form 22 February 2008

Exposure to high fatty acids (FAs) induces whole body and skeletal muscle insulin resistance. The globular form of the adipokine, adiponectin (gAd), stimulates FA oxidation and improves insulin sensitivity; however, its ability to prevent lipid-induced insulin resistance in humans has not been tested. The purpose of this study was to determine 1) whether acute (4 h) exposure to 2 mM palmitate would impair insulin signaling and glucose transport in isolated human skeletal muscle, 2) whether muscle from obese humans is more susceptible to the effects of palmitate, and 3) whether the presence of 2 mM palmitate + 2.5 µg/ml gAd (P+gAd) could prevent the effects of palmitate. Insulin-stimulated (10 mU/ml) glucose transport was not different, relative to control, following exposure to palmitate (–10%) or P+gAd (–3%) in lean muscle. In obese muscle, the absolute increase in glucose transport from basal to insulin-stimulated conditions was significantly decreased following palmitate (–55%) and P+gAd (–36%) exposure (control vs. palmitate; control vs. P+gAd, P < 0.05). There was no difference in the absolute increase in glucose transport between palmitate and P+gAd, indicating that in the presence of palmitate, gAd did not improve glucose transport. The palmitate-induced reduction in insulin-stimulated glucose transport in muscle from obese individuals may have been due to reduced Ser Akt (control vs. palmitate; P+gAd, P < 0.05) and Akt substrate 160 (AS160) phosphorylation (control vs. palmitate; P+gAd, P < 0.05). FA oxidation was significantly increased in muscle of lean and obese individuals in the presence of gAd (P < 0.05), suggesting that the stimulatory effects of gAd on FA oxidation may not be sufficient to entirely prevent palmitate-induced insulin resistance in obese muscle.

fatty acids; glucose transport; fat oxidation; adiponectin receptor isoform 1; adiponectin; diabetes



Address for reprint requests and other correspondence: A. B. Thrush, Dept. of Human Health and Nutritional Sciences, Animal Science and Nutrition Bldg., Rm 205, Univ. of Guelph, Guelph, Ontario N1G 2W1 (e-mail: athrush{at}uoguelph.ca)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.